{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:18:40Z","timestamp":1769584720588,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T00:00:00Z","timestamp":1423872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10096-015-2340-y","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T10:08:26Z","timestamp":1423822106000},"page":"1189-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia"],"prefix":"10.1007","volume":"34","author":[{"given":"M.","family":"D\u00f6ring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Eikemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Cabanillas Stanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-P.","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Handgretinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,14]]},"reference":[{"issue":"4","key":"2340_CR1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jac\/dkn027","volume":"61","author":"OA Cornely","year":"2008","unstructured":"Cornely OA, B\u00f6hme A, Reichert D, Reuter S, Maschmeyer G, Maertens J, Buchheidt D, Paluszewska M, Arenz D, Bethe U, Effelsberg J, L\u00f6venich H, Sieniawski M, Haas A, Einsele H, Eimermacher H, Martino R, Silling G, Hahn M, Wacker S, Ullmann AJ, Karthaus M; Multinational Case Registry of the Infectious Diseases Working Party of the German Society for Hematology and Oncology (2008) Risk factors for breakthrough invasive fungal infection during secondary prophylaxis. J Antimicrob Chemother 61(4):939\u2013946","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"2340_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048465","volume":"45","author":"BE Pauw de","year":"1999","unstructured":"de Pauw BE, Meunier F (1999) The challenge of invasive fungal infection. Chemotherapy 45(Suppl 1):1\u201314","journal-title":"Chemotherapy"},{"issue":"7","key":"2340_CR3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1185\/03007995.2010.487793","volume":"26","author":"WJ Steinbach","year":"2010","unstructured":"Steinbach WJ (2010) Invasive aspergillosis in pediatric patients. Curr Med Res Opin 26(7):1779\u20131787","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"2340_CR4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1185\/03007995.2010.487796","volume":"26","author":"T Zaoutis","year":"2010","unstructured":"Zaoutis T (2010) Candidemia in children. Curr Med Res Opin 26(7):1761\u20131768","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2340_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"SJ Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case\u2013fatality rate: systematic review of the literature. Clin Infect Dis 32(3):358\u2013366","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2340_CR6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/INF.0b013e3181b076b1","volume":"28","author":"HJ Dornbusch","year":"2009","unstructured":"Dornbusch HJ, Manzoni P, Roilides E, Walsh TJ, Groll AH (2009) Invasive fungal infections in children. Pediatr Infect Dis J 28(8):734\u2013737","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2340_CR7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01974614","volume":"13","author":"J Ninane","year":"1994","unstructured":"Ninane J (1994) A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 13(4):330\u2013337","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"2340_CR8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00520-006-0125-7","volume":"15","author":"A Simon","year":"2007","unstructured":"Simon A, Besuden M, Vezmar S, Hasan C, Lampe D, Kreutzberg S, Glasmacher A, Bode U, Fleischhack G (2007) Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants. Support Care Cancer 15(2):213\u2013220","journal-title":"Support Care Cancer"},{"issue":"3","key":"2340_CR9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jac\/dkt438","volume":"69","author":"S Yunus","year":"2014","unstructured":"Yunus S, Pieper S, Kolve H, Goletz G, J\u00fcrgens H, Groll AH (2014) Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit. J Antimicrob Chemother 69(3):815\u2013820","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2340_CR10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000238990","volume":"39","author":"J C\u00e1p","year":"1993","unstructured":"C\u00e1p J, Mojzesova A, Kayserova E, Bub\u00e1nska E, Hatiar K, Trupl J, Krcm\u00e9ry V Jr (1993) Fluconazole in children: first experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer. Chemotherapy 39(6):438\u2013442","journal-title":"Chemotherapy"},{"issue":"4","key":"2340_CR11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356(4):348\u2013359","journal-title":"N Engl J Med"},{"issue":"4","key":"2340_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356(4):335\u2013347","journal-title":"N Engl J Med"},{"issue":"3","key":"2340_CR13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cam4.225","volume":"3","author":"HC Kung","year":"2014","unstructured":"Kung HC, Johnson MD, Drew RH, Saha-Chaudhuri P, Perfect JR (2014) Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology\u2013oncology patients: a retrospective cohort study. Cancer Med 3(3):667\u2013673","journal-title":"Cancer Med"},{"issue":"6","key":"2340_CR14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00003495-199039060-00006","volume":"39","author":"SM Grant","year":"1990","unstructured":"Grant SM, Clissold SP (1990) Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39(6):877\u2013916","journal-title":"Drugs"},{"key":"2340_CR15","unstructured":"Pfizer GmbH (2011) Diflucan\u00ae: fluconazole. Fachinformation"},{"issue":"9","key":"2340_CR16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","volume":"138","author":"DJ Winston","year":"2003","unstructured":"Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC (2003) Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med 138(9):705\u2013713","journal-title":"Ann Intern Med"},{"issue":"2","key":"2340_CR17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/172.2.599","volume":"172","author":"EJ Anaissie","year":"1995","unstructured":"Anaissie EJ, Kontoyiannis DP, Huls C, Vartivarian SE, Karl C, Prince RA, Bosso J, Bodey GP (1995) Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J Infect Dis 172(2):599\u2013602","journal-title":"J Infect Dis"},{"issue":"4","key":"2340_CR18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jac\/42.4.531","volume":"42","author":"M Cuenca-Estrella","year":"1998","unstructured":"Cuenca-Estrella M, Rodr\u00edguez-Tudela JL, Mellado E, Mart\u00ednez-Su\u00e1rez JV, Monz\u00f3n A (1998) Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus. J Antimicrob Chemother 42(4):531\u2013533","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2340_CR19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/JCM.01900-06","volume":"45","author":"A Espinel-Ingroff","year":"2007","unstructured":"Espinel-Ingroff A, Canton E, Gibbs D, Wang A (2007) Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. J Clin Microbiol 45(3):858\u2013864","journal-title":"J Clin Microbiol"},{"key":"2340_CR20","unstructured":"Janssen-Cilag GmbH (2011) Sempera\u00ae 7 Kapseln: itraconazole. Fachinformation"},{"issue":"3","key":"2340_CR21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1399-3046.2006.00643.x","volume":"11","author":"L Grigull","year":"2007","unstructured":"Grigull L, Kuehlke O, Beilken A, Sander A, Linderkamp C, Schmid H, Seidemann K, Sykora KW, Schuster FR, Welte K (2007) Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy. Pediatr Transplant 11(3):261\u2013266","journal-title":"Pediatr Transplant"},{"issue":"3","key":"2340_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000076530","volume":"111","author":"M Potter","year":"2004","unstructured":"Potter M, Donnelly JP (2004) The role of itraconazole in preventing and treating systemic fungal infections in immunocompromised patients. Acta Haematol 111(3):175\u2013180","journal-title":"Acta Haematol"},{"issue":"24","key":"2340_CR23","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1200\/JCO.2003.04.052","volume":"21","author":"A Glasmacher","year":"2003","unstructured":"Glasmacher A, Prentice A, Gorschl\u00fcter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG (2003) Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. J Clin Oncol 21(24):4615\u20134626","journal-title":"J Clin Oncol"},{"issue":"4","key":"2340_CR24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2141.1999.01465.x","volume":"105","author":"GR Morgenstern","year":"1999","unstructured":"Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW (1999) A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol 105(4):901\u2013911","journal-title":"Br J Haematol"},{"issue":"1","key":"2340_CR25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2141.2005.05727.x","volume":"131","author":"KZ Vardakas","year":"2005","unstructured":"Vardakas KZ, Michalopoulos A, Falagas ME (2005) Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol 131(1):22\u201328","journal-title":"Br J Haematol"},{"key":"2340_CR26","unstructured":"MSD Sharp & Dohme GmbH (2013) Noxafil\u00ae 40\u00a0mg\/mL suspension: posaconazole. Fachinformation"},{"key":"2340_CR27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2334-12-263","volume":"12","author":"M D\u00f6ring","year":"2012","unstructured":"D\u00f6ring M, M\u00fcller C, Johann PD, Erbacher A, Kimmig A, Schwarze CP, Lang P, Handgretinger R, M\u00fcller I (2012) Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12\u00a0years of age following allogeneic stem cell transplantation. BMC Infect Dis 12:263","journal-title":"BMC Infect Dis"},{"issue":"4","key":"2340_CR28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10096-013-1998-2","volume":"33","author":"M D\u00f6ring","year":"2014","unstructured":"D\u00f6ring M, Blume O, Haufe S, Hartmann U, Kimmig A, Schwarze CP, Lang P, Handgretinger R, M\u00fcller I (2014) Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation. Eur J Clin Microbiol Infect Dis 33(4):629\u2013638","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2340_CR29","unstructured":"National Cancer Institute (NCI) (2006) Common terminology criteria for adverse events v3.0 (CTCAE). Cancer Therapy Evaluation Program. NCI, Bethesda. Available online at: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_40 . Cited 30 June 2014"},{"issue":"1","key":"2340_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7\u201314","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2340_CR31","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Mu\u00f1oz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46(12):1813\u20131821","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2340_CR32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ; Center for International Blood and Marrow Research; National Marrow Donor program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Disease Canada; Centers for Disease Control and Prevention (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15(10):1143\u20131238","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6b","key":"2340_CR33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1445-5994.2008.01723.x","volume":"38","author":"MA Slavin","year":"2008","unstructured":"Slavin MA, Heath CH, Thursky KA, Morrissey CO, Szer J, Ling LM, Milliken ST, Grigg AP (2008) Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy. Intern Med J 38(6b):468\u2013476","journal-title":"Intern Med J"},{"issue":"1","key":"2340_CR34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3324\/haematol.11665","volume":"94","author":"OA Cornely","year":"2009","unstructured":"Cornely OA, B\u00f6hme A, Buchheidt D, Einsele H, Heinz WJ, Karthaus M, Krause SW, Kr\u00fcger W, Maschmeyer G, Penack O, Ritter J, Ruhnke M, Sandherr M, Sieniawski M, Vehreschild JJ, Wolf HH, Ullmann AJ (2009) Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 94(1):113\u2013122","journal-title":"Haematologica"},{"issue":"2","key":"2340_CR35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","volume":"33","author":"CA Dykewicz","year":"2001","unstructured":"Dykewicz CA; Centers for Disease Control and Prevention (U.S.); Infectious Diseases Society of America; American Society of Blood and Marrow Transplantation (2001) Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 33(2):139\u2013144","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2340_CR36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fl\u00fcckiger U, Fr\u00eare P, Gachot B, Heinz WJ, Lass-Fl\u00f6rl C, Ribaud P, Thiebaut A, Cordonnier C; Third European Conference on Infections in Leukemia (2011) European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20142009 update. Bone Marrow Transplant 46(5):709\u2013718","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2340_CR37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pbc.24847","volume":"61","author":"M Science","year":"2014","unstructured":"Science M, Robinson PD, MacDonald T, Rassekh SR, Dupuis LL, Sung L (2014) Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients. Pediatr Blood Cancer 61(3):393\u2013400","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2340_CR38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/QCO.0b013e3283321ccc","volume":"22","author":"M Cohen-Wolkowiez","year":"2009","unstructured":"Cohen-Wolkowiez M, Moran C, Benjamin DK Jr, Smith PB (2009) Pediatric antifungal agents. Curr Opin Infect Dis 22(6):553\u2013558","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"2340_CR39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10096-010-0957-4","volume":"29","author":"T Lehrnbecher","year":"2010","unstructured":"Lehrnbecher T, Attarbaschi A, Duerken M, Garbino J, Gruhn B, Kontny U, L\u00fcer S, Phillips R, Scholz J, Wagner HJ, Wiesel T, Groll AH (2010) Posaconazole salvage treatment in paediatric patients: a multicentre survey. Eur J Clin Microbiol Infect Dis 29(8):1043\u20131045","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"2340_CR40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10096-010-1123-8","volume":"30","author":"S Cesaro","year":"2011","unstructured":"Cesaro S, Milano GM, Aversa F (2011) Retrospective survey on the off-label use of posaconazole in pediatric hematology patients. Eur J Clin Microbiol Infect Dis 30(4):595\u2013596","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"2340_CR41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2011.051995","volume":"97","author":"MR Ananda-Rajah","year":"2012","unstructured":"Ananda-Rajah MR, Grigg A, Downey MT, Bajel A, Spelman T, Cheng A, Thursky KT, Vincent J, Slavin MA (2012) Comparative clinical effectiveness of prophylactic voriconazole\/posaconazole to fluconazole\/itraconazole in patients with acute myeloid leukemia\/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period. Haematologica 97(3):459\u2013463","journal-title":"Haematologica"},{"issue":"4","key":"2340_CR42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/26.4.561","volume":"26","author":"RM Tucker","year":"1990","unstructured":"Tucker RM, Haq Y, Denning DW, Stevens DA (1990) Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 26(4):561\u2013566","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2340_CR43","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/jac\/dkr233","volume":"66","author":"CG Baxter","year":"2011","unstructured":"Baxter CG, Marshall A, Roberts M, Felton TW, Denning DW (2011) Peripheral neuropathy in patients on long-term triazole antifungal therapy. J Antimicrob Chemother 66(9):2136\u20132139","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2340_CR44","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.43.8.1955","volume":"43","author":"V Novelli","year":"1999","unstructured":"Novelli V, Holzel H (1999) Safety and tolerability of fluconazole in children. Antimicrob Agents Chemother 43(8):1955\u20131960","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2340-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2340-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2340-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T22:35:08Z","timestamp":1566340508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2340-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,14]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2340-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,14]]}}}